A single-center, randomized, parallel controlled study comparing the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer
Zhou Yijun
Ouyang Tao
Xie Yuntao
Wang Tianfeng
Fan Zhaoqing
He Yingjian
Lu Ai-Ping
Liu Yiqiang
Li Jinfeng
· 2016
期刊名称：
Breast Cancer Research and Treatment
2016 年
157 卷
3 期
摘要：
This study aimed to compare the efficacy and safety aspects of three anthracycline-based regimens as neoadjuvant chemotherapy in primary breast cancer. Five-hundred and one patients with clinical stage I??“III invasive breast cancer were randomly assigned to receive four cycles of neoadjuvant chemotherapy with either CEFci arm (5-Fu 200??mg/m
会员登录
